JP2007209324A - Method for producing iron supplement composition - Google Patents

Method for producing iron supplement composition Download PDF

Info

Publication number
JP2007209324A
JP2007209324A JP2006064834A JP2006064834A JP2007209324A JP 2007209324 A JP2007209324 A JP 2007209324A JP 2006064834 A JP2006064834 A JP 2006064834A JP 2006064834 A JP2006064834 A JP 2006064834A JP 2007209324 A JP2007209324 A JP 2007209324A
Authority
JP
Japan
Prior art keywords
iron
acid
supplement composition
raw material
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006064834A
Other languages
Japanese (ja)
Other versions
JP5028609B2 (en
Inventor
Makoto Yafuji
眞 八藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KANMONKAI KK
Kanmonkai Co Ltd
Original Assignee
KANMONKAI KK
Kanmonkai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KANMONKAI KK, Kanmonkai Co Ltd filed Critical KANMONKAI KK
Priority to JP2006064834A priority Critical patent/JP5028609B2/en
Publication of JP2007209324A publication Critical patent/JP2007209324A/en
Application granted granted Critical
Publication of JP5028609B2 publication Critical patent/JP5028609B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for producing an iron supplement composition having excellent absorption and a slight adverse effect. <P>SOLUTION: The iron supplement composition is obtained by adding a fixed amount of purified water to a pulverized iron raw material, cooking and sterilizing the iron raw material, mixing the sterilized substance with a koji mold and a glucide, primarily fermenting the mixture, mixing the fermented substance with a koji mold, yeast, a citric acid bacterium, a lactic acid bacterium or an acetic acid bacterium alone or a mixture of two or more of them and a glucide, secondarily fermenting the mixture, further mixing the fermented iron raw material with a carboxy group-containing organic acid selected from citric acid, lactic acid, acetic acid, tartaric acid and malic acid alone or a mixture of two or more of them, keeping and aging the mixture at 35-45°C and filtering and extracting the fermented substance. Being composed of an electrolyte in which the organic acid having a low adverse effect is dissociated from iron, the iron supplement composition more ameliorates a symptom such as anemia, etc., than a use of a conventional supplement. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

この発明は、鉄補給組成物の製造方法に関するものであり、一層詳細には、吸収性が良くしかも副作用の少ない鉄補給組成物の製造方法に関するものである。  The present invention relates to a method for producing an iron supplement composition, and more particularly to a method for producing an iron supplement composition having good absorbability and few side effects.

鉄Feは成人の体内に2g〜4g含まれており、主に血液中の赤血球のヘモグロビン、筋肉のミオグロビン及び肝臓のフェリチンなどに蓄えられ、一部は全身の細胞に広く分布している微量金属元素である。
通常、鉄は食物の形態として摂取されたのち、消化管内でFe2+やFe3+のイオンとして遊出し、一部はフェリチンおよびFe3+として血漿中に存在するが大部分はヘモグロビンの形成にあずかることが知られている。
Iron Fe is contained in adult body 2g-4g, and is stored mainly in erythrocyte hemoglobin, muscle myoglobin, liver ferritin, etc. in the blood, and some of them are widely distributed in cells throughout the body. It is an element.
Usually, iron is ingested as a form of food, and then it is released as Fe 2+ and Fe 3+ ions in the digestive tract, some of which are present in the plasma as ferritin and Fe 3+ , but most are involved in the formation of hemoglobin It has been known.

ヘモグロビンの鉄は酸素を運搬し、ミオグロビンの鉄は血中の酸素を細胞に取り入れる。そして各細胞の鉄は、酸素の活性化や栄養素の燃焼など体内の酸化還元反応に極めて重要な役割を果たしている。  Hemoglobin iron carries oxygen, and myoglobin iron takes oxygen from the blood into cells. The iron in each cell plays an extremely important role in the oxidation-reduction reactions in the body, such as oxygen activation and nutrient combustion.

このように鉄は生体上必要不可欠な金属であるが、消化管障害、代謝性疾病の罹患、月経などによる鉄欠乏性貧血は頻繁に発生しており、これらへの対処として、無機の鉄化合物あるいは有機の鉄化合物を有効成分とする鉄製剤(鉄補給組成物)が、注射、経口投与などにより利用されている。  In this way, iron is an indispensable metal in the living body, but iron deficiency anemia due to gastrointestinal tract disorders, metabolic diseases, menstruation, etc. frequently occurs. Or the iron formulation (iron supplement composition) which uses an organic iron compound as an active ingredient is utilized by injection, oral administration, etc.

これらのうち、無機の鉄製剤は、胃内で速やかにイオン化するため、胸焼け・嘔吐などのほか胃粘膜びらん・潰瘍等の消化管障害を惹起し、特に感受性の高い幼児においては中毒を引き起こすことが報告されている。
また、有機の鉄製剤は、無機の鉄製剤に見られるような副作用は低減しているものの、高用量を摂取しないと目的とする鉄補給効果が得られないことやコスト高につながることもあり、いずれの鉄製剤にも課題があるのが実情である。
Among these, inorganic iron preparations quickly ionize in the stomach, causing heartburn, vomiting, and other gastrointestinal disorders such as gastric mucosal erosion and ulcers, and cause poisoning in particularly sensitive infants. Has been reported.
In addition, organic iron preparations have reduced side effects as seen in inorganic iron preparations, but unless high doses are taken, the intended iron supplementation effect may not be achieved and costs may increase. In fact, all iron preparations have problems.

一方、多孔性基材の隙間に硫酸第一鉄などの無機鉄を配合するとともにこれをコーティングして無機鉄が徐々に放出されるようにして副作用を軽減するようにした徐放性の鉄製剤も開発されている。
しかしながら、このような鉄製剤は徐放性の付与に伴って溶解性が低下するため、所望の鉄補給効果を得るには高用量を摂取することになり、また食品に添加すると容易にイオン化して、無機の鉄製剤と同様の副作用を引き起こすことがあった。
On the other hand, a sustained release iron preparation that contains inorganic iron such as ferrous sulfate in the gap between porous substrates and coats it to gradually release inorganic iron to reduce side effects. Has also been developed.
However, since the solubility of such iron preparations decreases with the provision of sustained release, a high dose is taken to obtain the desired iron supplementation effect, and ionization easily occurs when added to foods. In some cases, side effects similar to those of inorganic iron preparations were caused.

このような事情から、鉄を効果的に生体に補給でき副作用も伴わない鉄製剤(鉄補給組成物)の開発が期待されている。  Under such circumstances, development of an iron preparation (iron supplement composition) that can effectively replenish iron to a living body and has no side effects is expected.

そこで、本発明ではこの課題を解決するため、わが国で古くから行われている発酵技術に着目し、原料として適宜の手段で微細化した鉄を醗酵させ、ついでこれに有機酸を混合して熟成することにより、有機酸と鉄が解離している電解質状態の鉄補給組成物として構成するものである。  Therefore, in the present invention, in order to solve this problem, attention is paid to fermentation techniques that have been performed in Japan for a long time, fermented iron as a raw material by an appropriate means, and then mixed with an organic acid for aging By doing so, it is configured as an iron supplement composition in an electrolyte state in which the organic acid and iron are dissociated.

具体的には、微細化した鉄原料に所定量の浄化水を加えて蒸煮殺菌し、つぎにこれに麹菌と糖質を加えて一次醗酵させたのち、麹菌、酵母、クエン酸菌、乳酸菌、酢酸菌を単独でまたはこれらの2種以上の混合物と糖質を加えて二次醗酵させ、さらにこの醗酵鉄原料にクエン酸、乳酸、酢酸、酒石酸、リンゴ酸から選ばれるカルボキシル基を有する有機酸を単独でまたはこれらの2種以上の混合物を混合して35℃〜45℃の温度に保持して熟成し、さらにこれを濾過抽出することを特徴とするものである。  Specifically, a predetermined amount of purified water is added to the refined iron raw material and sterilized by steaming. Next, koji molds and saccharides are added thereto, followed by primary fermentation, koji molds, yeast, citric acid bacteria, lactic acid bacteria, Acetic acid bacteria alone or a mixture of two or more of them and a saccharide are subjected to secondary fermentation, and the fermented iron raw material has a carboxyl group selected from citric acid, lactic acid, acetic acid, tartaric acid and malic acid. Singly or in a mixture of two or more of these, and kept at a temperature of 35 ° C. to 45 ° C. for aging, and further filtered and extracted.

この場合、醗酵鉄原料を熟成する際に、醗酵鉄原料に対して1重量%〜8重量%のL−アスコルビン酸(ビタミンC)を加えるのが好ましい。  In this case, it is preferable to add 1% by weight to 8% by weight of L-ascorbic acid (vitamin C) with respect to the fermented iron raw material when aging the fermented iron raw material.

また、この熟成に際しては、遠赤外線照射およびエレクトロン供給雰囲気において醗酵鉄原料を流動させながら行うのが好適である。  Further, this aging is preferably carried out while allowing the fermented iron raw material to flow in a far-infrared irradiation and electron supply atmosphere.

さらに、本発明は上記製造方法により得られた鉄補給組成物も包含するものである。  Furthermore, the present invention also includes an iron supplement composition obtained by the above production method.

本発明に係る鉄補給組成物の製造方法によれば;
(1)微細化した鉄原料と浄化水に麹菌と糖質を加えて一次醗酵させたのち、麹菌、酵母、クエン酸菌、乳酸菌、酢酸菌を単独でまたはこれらの2種以上の混合物と糖質を加えて二次醗酵させ、さらにこの醗酵鉄原料にクエン酸、乳酸、酢酸、酒石酸、リンゴ酸から選ばれるカルボキシル基を有する有機酸を単独でまたはこれらの2種以上の混合物を混合して35℃〜45℃の温度に保持して熟成し、さらにこれを濾過抽出することにより有機酸と鉄が解離している電解質の状態として構成するので吸収性が良く副作用の伴なわない鉄補給組成物を得ることができる。
(2)醗酵鉄原料に有機酸を加えて熟成する際、鉄の吸収促進物質として知られるビタミンC(L−アスコルビン酸)を加えるので、吸収性をさらに向上することができる。
(3)得られた鉄補給組成物は有機酸鉄となっているので胃液(HCl)の影響を受けることなく吸収されるため副作用は殆ど起こらず、吸収性も良いことから、従来のサプリメント(ヘム鉄)よりも貧血などの状態を改善できき、また、食品加工の分野においても品質維持や風味の改善を図ることができ、さらには、家畜や愛玩動物の飼料添加材、鉄欠乏性疾患の予防または治療用などにも供することができる、
など種々の効果を奏するものである。
According to the method for producing an iron supplement composition according to the present invention;
(1) After first fermentation with koji mold and sugar added to refined iron raw material and purified water, koji mold, yeast, citric acid bacteria, lactic acid bacteria, acetic acid bacteria alone or a mixture of two or more of these and sugar In addition, the fermented iron raw material is mixed with an organic acid having a carboxyl group selected from citric acid, lactic acid, acetic acid, tartaric acid and malic acid alone, or a mixture of two or more of these. Aged and maintained at a temperature of 35 ° C to 45 ° C, and further filtered and extracted to form an electrolyte state in which the organic acid and iron are dissociated. You can get things.
(2) When an organic acid is added to the fermented iron raw material and ripened, vitamin C (L-ascorbic acid) known as an iron absorption promoting substance is added, so that the absorbability can be further improved.
(3) Since the obtained iron supplement composition is an organic acid iron, it is absorbed without being affected by gastric juice (HCl), so there are almost no side effects and good absorbency. Heme iron can improve conditions such as anemia, and can also maintain quality and improve flavor in the field of food processing. Furthermore, feed additives for livestock and pets, iron deficiency diseases Can also be used for prevention or treatment of
Various effects are exhibited.

次に、本発明に係る鉄補給組成物の製造方法における最良の実施の形態を例示し、以下詳細に説明する。
図1において、本発明に係る鉄補給組成物の製造方法においては、まず、従来公知の手段により微細化した原料鉄粉10を用意し、この原料鉄粉10の重量に対して8倍量〜15倍量の水、好ましくは、上水から塩素などの不純物を除去した精製水12を混合して10分程度煮沸したのち、35℃〜40℃まで冷却する。
次に煮沸処理した原料鉄粉10と精製水12の混合物14に対して10重量%〜30重量%の麹菌16と、この麹菌16と略同量の糖質18を加え加熱ヒータなどで35℃〜40℃で10日ほど保持することにより一次醗酵させる。
この場合、麹菌の添加量が10重量%未満であると充分な醗酵が行われず、また30重量%を超えると量が多すぎて経済性が低下することになる。
Next, the best embodiment of the method for producing an iron supplement composition according to the present invention will be exemplified and described in detail below.
In FIG. 1, in the method for producing an iron supplement composition according to the present invention, first, a raw iron powder 10 refined by a conventionally known means is prepared, and the amount of the raw iron powder 10 is 8 times the amount of the raw iron powder 10. After 15 times the amount of water, preferably purified water 12 from which impurities such as chlorine have been removed, is mixed and boiled for about 10 minutes, it is cooled to 35 ° C. to 40 ° C.
Next, 10% by weight to 30% by weight of koji mold 16 and approximately the same amount of saccharide 18 as that of koji mold 16 are added to the mixture 14 of raw material iron powder 10 and purified water 12 that has been boiled, and heated at 35 ° C. with a heater or the like. Primary fermentation is carried out by holding at ~ 40 ° C for about 10 days.
In this case, if the addition amount of the koji mold is less than 10% by weight, sufficient fermentation is not performed, and if it exceeds 30% by weight, the amount is too large and the economy is lowered.

得られた一次醗酵鉄原料20には、糖質18を10重量%程度補填するとともに10重量%〜20重量%の麹菌、酵母、クエン酸菌、乳酸菌、酢酸菌を単独でまたはこれらの2種以上の混合物22を加え、再び35℃〜40℃で10日ほど保持することにより二次醗酵させる。
なお、一次醗酵鉄原料20に加える麹菌、酵母、クエン酸菌、乳酸菌、酢酸菌あるいはこれらの混合物22が10重量%未満であると醗酵が充分行われず、また20重量%を超えると量が多すぎて経済性が低下してしまう。
The obtained primary fermented iron material 20 is supplemented with about 10% by weight of carbohydrate 18 and 10% to 20% by weight of koji molds, yeasts, citric acid bacteria, lactic acid bacteria, and acetic acid bacteria alone or two of them. The above mixture 22 is added, and the mixture is again fermented by holding at 35 ° C. to 40 ° C. for about 10 days.
In addition, fermentation is not sufficiently performed if the koji mold, yeast, citric acid bacteria, lactic acid bacteria, acetic acid bacteria or a mixture 22 thereof added to the primary fermented iron raw material 20 is less than 10% by weight, and if it exceeds 20% by weight, the amount is large. It will be too economical.

このようにして得られた二次醗酵物24には、10重量%〜40重量%のクエン酸、乳酸、酢酸、酒石酸、リンゴ酸などから選ばれるカルボキシル基を有する有機酸を単独でまたはこれらの2種以上を混合した有機酸26を加えるとともに加熱ヒータなどで35℃〜40℃に保持することにより熟成する。
この場合、クエン酸、乳酸、酢酸、酒石酸、リンゴ酸などのカルボキシル基を有する有機酸あるいは混合有機酸26が10重量%未満であると二次醗酵物22の熟成に時間がかかり、また40重量%を超えると有機酸分が多くなりすぎて酸味が強くなってしまう。
The secondary fermentation product 24 thus obtained contains 10% to 40% by weight of an organic acid having a carboxyl group selected from citric acid, lactic acid, acetic acid, tartaric acid, malic acid and the like alone or these. The mixture is aged by adding an organic acid 26 in which two or more kinds are mixed and maintaining the temperature at 35 ° C. to 40 ° C. with a heater.
In this case, when the organic acid having a carboxyl group or mixed organic acid 26 such as citric acid, lactic acid, acetic acid, tartaric acid, malic acid or the like is less than 10% by weight, it takes time to mature the secondary fermentation product 22, and 40% by weight. If it exceeds 50%, the organic acid content becomes too much and the acidity becomes strong.

なお、二次醗酵物24の熟成時に、この二次醗酵物24の重量に対して1重量%〜8重量%、好ましくは、5重量%程度のL−アスコルビン酸28を混合する。このようにL−アスコルビン酸26を加えることにより、鉄の吸収性をより高めることができるものである。  In addition, when the secondary fermentation product 24 is aged, 1% by weight to 8% by weight, preferably about 5% by weight of L-ascorbic acid 28 is mixed with the weight of the secondary fermentation product 24. Thus, by adding L-ascorbic acid 26, the absorbability of iron can be improved more.

このように35℃〜40℃に保持された二次醗酵物24とL−アスコルビン酸28との混合醗酵物30は、好ましくは、遠赤外線照射下および静電磁場、エレクトロン(−e)供給雰囲気においてゆっくり撹拌しながら流動させることによりさらに10日ほど熟成し、原料鉄10の液化(イオン化)を促進して有機酸中に解離させる。  The mixed fermented product 30 of the secondary fermented product 24 and L-ascorbic acid 28 thus maintained at 35 ° C. to 40 ° C. is preferably irradiated with far infrared rays, in an electrostatic magnetic field, and in an electron (−e) supply atmosphere. The solution is aged for about 10 days by allowing it to flow while slowly stirring, and promotes liquefaction (ionization) of the raw material iron 10 to dissociate it into an organic acid.

そして、混合醗酵物30中の鉄成分が充分に解離したら、2〜3週間程静置したのち紫外線などにより殺菌し、鉄補給組成物32として濾過抽出する。
この抽出によって得られた鉄補給液状組成物32は、金釘臭ともいわれる独特の鉄臭さや収斂味がほとんどなく、100m中に約2.5%(2454mg)の鉄Feを含有していた。
When the iron component in the mixed fermented product 30 is sufficiently dissociated, the mixture is allowed to stand for about 2 to 3 weeks and then sterilized by ultraviolet rays or the like, and filtered and extracted as the iron supplement composition 32.
The iron-supplemented liquid composition 32 obtained by this extraction had almost no unique iron odor or astringent taste, also referred to as a gold nail odor, and contained about 2.5% (2454 mg) of iron Fe in 100 m.

実験例
次に、上述の方法により得られた鉄補給組成物32と、非ヘム鉄に比べるとはるかに吸収性の良いヘム鉄を使用したサプリメント鉄剤A(A社製)の吸収性を比較した。
Experimental Example Next, the iron replenishment composition 32 obtained by the above-described method was compared with the absorption of the supplement iron agent A (manufactured by A company) using heme iron, which is much more absorbable than non-heme iron. .

具体的には、試料としてのラット(Wister系、8週齢、250g)の頚動脈にカテーテルを挿入して血中クリアランス用のモデルラットを作成した。そしてこれらモデルラットに鉄補給組成物32とサプリメント鉄剤Aをそれぞれ経口投与(3.75mg/250g)し、経時的に採血して血清を分離し、その血清鉄量(Nitroso−PSAP直接法)と血清ヘモグロビン量(SLS−ヘモグロビン法)を測定したのち、トータル鉄から血清ヘモグロビン鉄量を差し引いて血清鉄量(血中鉄量)を計算した。なお、この血清鉄量は、血清の濃度変化を考慮して血清ヘモグロビン量により補正をかけて一定の濃度(初期値)を基準として算出した。また、血清鉄量の測定は、経口投与前(0時間)、経口投与後0.5時間、1時間、2時間、3時間、5時間、8時間まで行い、表1の結果を得た。  Specifically, a model rat for blood clearance was prepared by inserting a catheter into the carotid artery of a rat (Wister system, 8 weeks old, 250 g) as a sample. These model rats were orally administered with iron supplement composition 32 and supplement iron A (3.75 mg / 250 g) respectively, blood was collected over time to separate serum, and the serum iron content (Nitroso-PSAP direct method) and After measuring the amount of serum hemoglobin (SLS-hemoglobin method), the amount of serum iron (blood iron amount) was calculated by subtracting the amount of serum hemoglobin iron from the total iron. The amount of serum iron was calculated on the basis of a constant concentration (initial value) after correcting for the amount of serum hemoglobin in consideration of changes in serum concentration. The serum iron amount was measured before oral administration (0 hour), 0.5 hours, 1 hour, 2 hours, 3 hours, 5 hours, and 8 hours after oral administration, and the results shown in Table 1 were obtained.

Figure 2007209324
Figure 2007209324

この結果、表1および図2からも明らかなように、血中鉄量は鉄補給組成物32およびサプリメント鉄剤Aのいずれも経口投与後0.5時間で最大となり、鉄補給組成物32の鉄量はサプリメント鉄剤Aの約3倍近くであった。また、サプリメント鉄剤Aの血中鉄量は1時間30分前後にはほぼ通常値に戻ったのに対し、鉄補給組成物32は5時間程度経過してから通常値に戻り、その吸収時間はサプリメント鉄剤Aの4.2倍も長かった。  As a result, as is apparent from Table 1 and FIG. 2, the amount of iron in the blood reached the maximum at 0.5 hours after oral administration of both the iron supplement composition 32 and supplement iron A, and the iron supplement composition 32 had an iron content. The amount was nearly three times that of supplement iron A. The amount of iron in supplement iron A returned to the normal value around 1 hour 30 minutes, whereas the iron supplement composition 32 returned to the normal value after about 5 hours, and the absorption time was It was 4.2 times longer than Supplement Iron A.

これは、イオン化された鉄は十二指腸や小腸上部で吸収されるためそこでの吸収が良く、鉄補給組成物32は時間経過から推測すると小腸中部から下部にかけても鉄イオンを吸収していることがうかがえる。また、血中鉄量を高濃度に保持していた鉄補給組成物30は、非ヘム鉄といっても有機酸と鉄が解離している電解質の状態のため吸収性が良いからである。  This is because ionized iron is absorbed in the duodenum and upper part of the small intestine, so that the iron supplement composition 32 absorbs iron ions from the middle part to the lower part of the small intestine. . In addition, the iron supplement composition 30 that has kept the amount of iron in the blood at a high concentration has good absorbability because it is an electrolyte in which the organic acid and iron are dissociated even though it is non-heme iron.

なお、鉄補給組成物32は、血中鉄量が最大となった0.5時間から30分経後に一度下がり、1時間の間その量を略保持して2時間後からまた低下しているが、これは小腸の上・中・下における吸収の継続なのか、血中の鉄イオンがトランスフェリンやミオゴロビンなどに吸収され貯蔵に回ったものなのか、あるいは、肝臓・脾臓などの貯蔵に回っているものなのか明確ではないが、一般的に吸収性の良好なヘム鉄を使用したサプリメント鉄剤Aに比べ、鉄補給組成物32の吸収性の良さとその持続性に際立った優位性が認められる。従って、従来のサプリメントを使用するよりも少量で負荷もかからずに貧血などの状態をより改善できるものである。  It should be noted that the iron supplement composition 32 once dropped after 30 minutes from 0.5 hours when the blood iron amount reached the maximum, and substantially decreased for 1 hour, and then decreased again after 2 hours. However, is this due to continued absorption in the upper, middle, and lower parts of the small intestine, whether iron ions in the blood are absorbed by transferrin and myogolobine, etc., or are stored for storage, or are stored for storage of the liver, spleen, etc. Although it is not clear whether or not it is, it is generally recognized that the iron supplement composition 32 has superior absorbability and its superiority compared to supplement iron agent A using heme iron with good absorbability. . Therefore, anemia and other conditions can be further improved with a small amount and no load compared with the use of conventional supplements.

先に述べたように本発明方法により得られる鉄補給組成物は、副作用の少ない有機酸と鉄が解離している電解質として構成されているので貧血などの状態を従来のサプリメントを使用したときよりも改善できるだけでなく、食品加工の分野においても0.1%程度の微量を添加して処理することにより対象とする食品の品質維持や風味の改善を図ることができ、また、家畜や愛玩動物の飼料添加材、鉄欠乏性疾患の予防または治療用など種々の分野、用途に供することができるものである。  As described above, the iron supplement composition obtained by the method of the present invention is configured as an electrolyte in which iron is dissociated from an organic acid with few side effects, so that the state of anemia or the like is more than when a conventional supplement is used. In addition to improving the quality of food products, it is possible to improve the quality and flavor of target foods by adding a small amount of about 0.1% in the field of food processing. Can be used in various fields and applications such as feed additives, and prevention or treatment of iron deficiency diseases.

本発明に係る鉄補給組成物の製造方法の好適な実施の形態を示す概略工程説明図である。It is a schematic process explanatory drawing which shows suitable embodiment of the manufacturing method of the iron supplement composition which concerns on this invention. 図1に示す方法によって得られた鉄補給組成物と市販のサプリメント鉄剤をラットに経口投与したときの血中鉄量の変化を示す表1の特性曲線図である。It is a characteristic curve figure of Table 1 which shows the change of the amount of iron in blood when the iron supplement composition obtained by the method shown in FIG. 1 and a commercially available supplement iron agent are orally administered to a rat.

符号の説明Explanation of symbols

10…原料鉄粉、
12…精製水、
14…原料鉄粉と精製水の混合物、
16…麹菌、
18…糖質、
20…一次醗酵鉄原料、
22…麹菌または麹菌などの混合物、
24…二次醗酵物、
26…有機酸あるいは混合有機酸、
28…L−アスコルビン酸、
30…混合醗酵物、
32…鉄補給組成物、
10 ... Raw iron powder,
12 ... purified water,
14 ... A mixture of raw iron powder and purified water,
16 ... Koji,
18 ... sugar,
20 ... Primary fermented iron raw material,
22 ... gonococcus or a mixture of gonococci,
24 ... secondary fermentation product,
26: Organic acid or mixed organic acid,
28 ... L-ascorbic acid,
30 ... Mixed fermented product,
32. Iron supplement composition,

Claims (4)

微細化した鉄原料に所定量の浄化水を加えて蒸煮殺菌し、つぎにこれに麹菌と糖質を加えて一次醗酵させたのち、麹菌、酵母、クエン酸菌、乳酸菌、酢酸菌を単独でまたはこれらの2種以上の混合物と糖質を加えて二次醗酵させ、さらにこの醗酵鉄原料にクエン酸、乳酸、酢酸、酒石酸、リンゴ酸から選ばれるカルボキシル基を有する有機酸を単独でまたはこれらの2種以上の混合物を混合して35℃〜45℃の温度に保持して熟成し、さらにこれを濾過抽出することを特徴と鉄補給組成物の製造方法。  Add the specified amount of purified water to the refined iron raw material and sterilize it by steaming. Next, koji mold and saccharides are added to this, followed by primary fermentation, then koji mold, yeast, citric acid bacteria, lactic acid bacteria, and acetic acid bacteria alone. Alternatively, a mixture of two or more of these and a saccharide is added to cause secondary fermentation. Further, an organic acid having a carboxyl group selected from citric acid, lactic acid, acetic acid, tartaric acid and malic acid is used alone or in these fermented iron raw materials. A method for producing an iron supplement composition, characterized in that two or more of the above mixtures are mixed and aged at 35 to 45 ° C. and further filtered and extracted. 醗酵鉄原料を熟成する際に、この醗酵鉄原料に対して1重量%〜8重量%のL−アスコルビン酸を加えることからなる請求項1に記載の鉄補給組成物の製造方法。  2. The method for producing an iron supplement composition according to claim 1, wherein 1% by weight to 8% by weight of L-ascorbic acid is added to the fermented iron raw material when aging the fermented iron raw material. 醗酵鉄原料の熟成は、遠赤外線照射およびエレクトロン供給雰囲気において流動させながら行うことからなる請求項1または2に記載の鉄補給組成物の製造方法。  The method for producing an iron supplement composition according to claim 1 or 2, wherein the aging of the fermented iron raw material is performed while flowing in a far-infrared irradiation and electron supply atmosphere. 請求項1〜3のいずれかに記載の製造方法により得られた鉄補給組成物。  The iron supplement composition obtained by the manufacturing method in any one of Claims 1-3.
JP2006064834A 2006-02-13 2006-02-13 Method for producing iron supplement composition Active JP5028609B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006064834A JP5028609B2 (en) 2006-02-13 2006-02-13 Method for producing iron supplement composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006064834A JP5028609B2 (en) 2006-02-13 2006-02-13 Method for producing iron supplement composition

Publications (2)

Publication Number Publication Date
JP2007209324A true JP2007209324A (en) 2007-08-23
JP5028609B2 JP5028609B2 (en) 2012-09-19

Family

ID=38488266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006064834A Active JP5028609B2 (en) 2006-02-13 2006-02-13 Method for producing iron supplement composition

Country Status (1)

Country Link
JP (1) JP5028609B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009100725A (en) * 2007-10-19 2009-05-14 Makoto Yafuji Method for producing dispersion of ceramides composition
JP2010090096A (en) * 2008-10-08 2010-04-22 Makoto Yafuji Method of manufacturing improved keratin
JP2010254658A (en) * 2009-04-24 2010-11-11 Makoto Yafuji Method for producing antibacterial ionized metal composition
WO2014042046A1 (en) * 2012-09-13 2014-03-20 オリエンタル酵母工業株式会社 High-iron-content yeast extract, method for producing same, and food product
JP2014200183A (en) * 2013-04-03 2014-10-27 オリエンタル酵母工業株式会社 Red rice additive and production method thereof, red rice and production method thereof, and kit for production of red rice additive
WO2020031141A1 (en) * 2018-08-10 2020-02-13 Cura Global Health (Bvi) Limited Method for treating iron deficiency
CN112220047A (en) * 2020-10-28 2021-01-15 江苏海创知识产权服务有限公司 Ferric pyrophosphate and production process thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004057183A (en) * 2002-07-31 2004-02-26 Makoto Yafuji Method for producing agaric mushroom extract
JP2005041851A (en) * 2003-07-23 2005-02-17 Makoto Yafuji Supplement composed mainly of vitamin and bonded with ionized mineral
JP2005220331A (en) * 2004-02-04 2005-08-18 Makoto Yafuji Method for producing low-molecular chitosan

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004057183A (en) * 2002-07-31 2004-02-26 Makoto Yafuji Method for producing agaric mushroom extract
JP2005041851A (en) * 2003-07-23 2005-02-17 Makoto Yafuji Supplement composed mainly of vitamin and bonded with ionized mineral
JP2005220331A (en) * 2004-02-04 2005-08-18 Makoto Yafuji Method for producing low-molecular chitosan

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009100725A (en) * 2007-10-19 2009-05-14 Makoto Yafuji Method for producing dispersion of ceramides composition
JP2010090096A (en) * 2008-10-08 2010-04-22 Makoto Yafuji Method of manufacturing improved keratin
JP2010254658A (en) * 2009-04-24 2010-11-11 Makoto Yafuji Method for producing antibacterial ionized metal composition
CN104797702A (en) * 2012-09-13 2015-07-22 东方酵母工业株式会社 High-iron-content yeast extract, method for producing same, and food product
KR20150056593A (en) * 2012-09-13 2015-05-26 오리엔탈 이스트 컴파니 리미티드 High-Iron-Content Yeast Extract, Method for Producing Same, And Food Product
WO2014042046A1 (en) * 2012-09-13 2014-03-20 オリエンタル酵母工業株式会社 High-iron-content yeast extract, method for producing same, and food product
JPWO2014042046A1 (en) * 2012-09-13 2016-08-18 オリエンタル酵母工業株式会社 High iron content yeast extract, method for producing the same, and food
CN104797702B (en) * 2012-09-13 2017-07-28 东方酵母工业株式会社 Yeast extract and its manufacture method and food containing High Content Ferric Ion
TWI629939B (en) * 2012-09-13 2018-07-21 東方酵母工業股份有限公司 High-iron-content yeast extract, method for producing the same, and foods
KR102196568B1 (en) 2012-09-13 2020-12-29 오리엔탈 이스트 컴파니 리미티드 High-Iron-Content Yeast Extract, Method for Producing Same, And Food Product
JP2014200183A (en) * 2013-04-03 2014-10-27 オリエンタル酵母工業株式会社 Red rice additive and production method thereof, red rice and production method thereof, and kit for production of red rice additive
WO2020031141A1 (en) * 2018-08-10 2020-02-13 Cura Global Health (Bvi) Limited Method for treating iron deficiency
CN112220047A (en) * 2020-10-28 2021-01-15 江苏海创知识产权服务有限公司 Ferric pyrophosphate and production process thereof

Also Published As

Publication number Publication date
JP5028609B2 (en) 2012-09-19

Similar Documents

Publication Publication Date Title
JP5028609B2 (en) Method for producing iron supplement composition
Willhite et al. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts
CN103432161B (en) Multivitamin mineral effervescent tablet and preparation method thereof
KR102057555B1 (en) Carboxylic Acid Mixtures to Treat Patients with Renal Failure
JP6620296B2 (en) Feed additive composition for reducing methane production in ruminants
RU2508409C2 (en) Sugar-containing product manufacture method
JP4596304B2 (en) Growth hormone secretion promoting composition
CN107279296A (en) A kind of formula food of suitable diabetes and preparation method thereof
KR20140067579A (en) A manufacturing method of overhang solution pellet and overhang solution pellet munufactured by the same
CN110122707A (en) One kind is relieved the effect of alcohol fruit drink and preparation method thereof
JP6710098B2 (en) Nutritional composition and dietary supplement
JPH06284872A (en) Health and beauty promoter, blood pressure suppressor and constipation improver having sod action
CN103565811B (en) Compound vitamin lyophilized preparation for injection and its preparation method
JP3761510B2 (en) Foods that improve or prevent hay fever
CN108853476A (en) A kind of iron protein succinylate oral solution and preparation method thereof
JPH11199492A (en) Production of calcium-supplying agent
CN109394788A (en) Pet is enriched blood liver extract oral liquor and preparation method thereof
Ghada et al. Effect of different types of oral iron therapy used for the treatment of iron deficiency anemia and their effects on some hormones and minerals in anemic rats
CN110862900A (en) Preparation method and application of fruit and vegetable fermentation liquor
CN101731627A (en) Drink or oral liquid capable of supplementing various trace elements
CN108652010B (en) Omega 3 quick solvent and preparation method thereof
EP2638913B1 (en) Method for producing bioactive agent, bioactive agent produced thereby, cosmetic, freshness-maintaining agent, growth promotion agent, soil conditioning agent, and pharmaceutical stock solution
JP2002080376A (en) Biologically active agent and medicine
WO2017014153A1 (en) Cyclic dipeptide-containing anti-obesity composition
KR20190014220A (en) Composition of mixed ferment extraction liquid for hangover elimination and hangover eliminator containing composition as effective ingredient thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090120

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20110713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120322

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120508

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20120524

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20120531

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20120531

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120531

R150 Certificate of patent or registration of utility model

Ref document number: 5028609

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150706

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531